Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors
- PMID: 7507180
- PMCID: PMC236573
- DOI: 10.1128/JVI.68.2.1258-1263.1994
Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors
Abstract
Human immunodeficiency virus type 1 infection of mononuclear phagocytes has been implicated in disease manifestations, but postentry viral replication events in these cells have not been well characterized. Productive infection of activated T cells is associated with cell proliferation and accumulation of full-length viral DNA within 6 h. In infected, nondividing quiescent peripheral blood lymphocytes, reverse transcription is aborted prior to full-length viral DNA formation. For nondividing, cultured mononuclear phagocytes, we now report a third pattern of reverse transcription with relatively slow kinetics, in which full-length viral DNA did not accumulate until 36 to 48 h. The reverse transcription rate in mononuclear phagocytes could be accelerated by addition of exogenous nucleotide precursors, but still not to the rate seen in activated T cells. These results indicate that substrate limitations in mononuclear phagocytes slow but do not arrest human immunodeficiency virus type 1 reverse transcription.
Similar articles
-
Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1).J Clin Invest. 1992 Jan;89(1):176-83. doi: 10.1172/JCI115559. J Clin Invest. 1992. PMID: 1370293 Free PMC article.
-
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.Virology. 1995 Feb 1;206(2):935-44. doi: 10.1006/viro.1995.1016. Virology. 1995. PMID: 7531918
-
Effects of zidovudine-selected human immunodeficiency virus type 1 reverse transcriptase amino acid substitutions on processive DNA synthesis and viral replication.J Virol. 1996 Apr;70(4):2146-53. doi: 10.1128/JVI.70.4.2146-2153.1996. J Virol. 1996. PMID: 8642636 Free PMC article.
-
HIV-1 entry and reverse transcription in macrophages.J Leukoc Biol. 1994 Sep;56(3):273-7. doi: 10.1002/jlb.56.3.273. J Leukoc Biol. 1994. PMID: 8083599 Review.
-
Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription.Adv Virus Res. 1996;46:97-163. doi: 10.1016/s0065-3527(08)60071-8. Adv Virus Res. 1996. PMID: 8824699 Review. No abstract available.
Cited by
-
Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle.J Virol. 2000 Feb;74(4):1712-7. doi: 10.1128/jvi.74.4.1712-1717.2000. J Virol. 2000. PMID: 10644341 Free PMC article.
-
Raltegravir: molecular basis of its mechanism of action.Eur J Med Res. 2009 Nov 24;14 Suppl 3(Suppl 3):5-16. doi: 10.1186/2047-783x-14-s3-5. Eur J Med Res. 2009. PMID: 19959411 Free PMC article. Review.
-
The inside out of lentiviral vectors.Viruses. 2011 Feb;3(2):132-159. doi: 10.3390/v3020132. Epub 2011 Feb 14. Viruses. 2011. PMID: 22049307 Free PMC article. Review.
-
miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1.PLoS Pathog. 2009 Jan;5(1):e1000263. doi: 10.1371/journal.ppat.1000263. Epub 2009 Jan 16. PLoS Pathog. 2009. PMID: 19148268 Free PMC article.
-
Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent.J Virol. 1999 May;73(5):3649-60. doi: 10.1128/JVI.73.5.3649-3660.1999. J Virol. 1999. PMID: 10196257 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources